Causes and predictors of death in South Africans with systemic lupus erythematosus

Rheumatology

Volumn 46, Issue 9, 2007, Pages 1487-1491

  Wadee, S ^a   Tikly, M ^a,c   Hopley, M ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b Boehringer Ingelheim ZA   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Africa; Blacks; Lupus; Mortality

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTHRITIS; ARTICLE; CAUSE OF DEATH; COMORBIDITY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HYPOCOMPLEMENTEMIA; INDIGENT; INFECTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; MORTALITY; MULTIVARIATE ANALYSIS; NEGRO; NEPHRITIS; OUTCOMES RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEX RATIO; SOUTH AFRICA; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC LUPUS ERYTHEMATOSUS; UNEMPLOYMENT; UNIVARIATE ANALYSIS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CAUSE OF DEATH; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; RETROSPECTIVE STUDIES; SOUTH AFRICA; SURVIVAL ANALYSIS;

EID: 34548216849     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem180     Document Type: Article

References (34)

1. Abu-Shakra M, Gladman DD, Urowitz MB. Mortality studies in SLE: How far can we improve survival of patients with SLE. Autoimmun Rev 2004;3:418-20.
2. Uramoto K, Michet CJ Jr, Thumboo J, Sunku J, O'Fallon WM, Gabriel SE. Trends in the incidence and mortality of systemic lupus erythematosus. Arthritis Rheum 1999;42:46-50.
3. Alzeer AH, Al-Artaj A, Basha SJ et al. Outcome of patients with systemic lupus erythematosus in intensive care unit. Lupus 2004;13:537-42.
4. Carvera R, Khamashta MA, Font J et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine 1999;78:167-75.
5. Stahl-Hallengren C, Jonsen A, Nived O, Sturfelt G. Incidence studies of systemic lupus erythematosus in Southern Sweden: Increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol 2000;27:685-91.
6. Moss KE, Ioannou Y, Sultan SM, Haq I, Isenberg DA. Oulcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis 2002;61:409-13.
7. Doria A, Iaccarino L, Ghirardello A et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 2006;119:700-6.
8. Dubois EL. Prednisone and prednisolone in the treatment of systemic lupus erythematosus. J Am Med Assoc 1956;161:427-33.
9. Bernatsky S, Bolvin JF, Joseph L et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006;54:2550-7.
10. Houman MH, Smiti-Khanfir M, Ben Ghorbell I, Miled M. Systemic lupus erythematosus in Tunisia: Demographic and clinical analysis of 100 patients. Lupus 2004;13:204-11.
11. Malaviya AN, Chandrasekaran AN, Kumar A, Shamar PN. Systemic lupus erythematosus in India. Lupus 1997;6:690-700.
12. Ka MM, Diallo S, Kane A et al. Systemic lupus erythematosus and lupus syndromes in Senegal. A retrospective study of 30 patients seen over 10 years, Rev Rhum Engl Ed 1998;65:471-6.
13. Kasitanon N, Louthrenoo, W, Sukftawut W, Vichainun R. Causes of death and prognostic factors in Thai patients with systemic lupus erythematosus. Asian Pac J Allergy Immunoll 2002;20:85-91.
14. Nossent JC. Course and prognostic value of Systemic Lupus Erythematosus Disease Activity Index in black Caribbean patients. Semin Arthritis Rheum 1993;23:16-21.
15. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus arythematosus. Results from a single center. I. Causes of death. J Rheumatol 1995;22:1259-454.
16. Molokhia M, McKeigue PM, Cuadrado M, Hughes G. Systemic lupus erythematosus in migrants from west Africa compared with Afro-Caribbean people in the UK. Lancet 2001;357:1414-5.
17. Bae SC, Fraser P, Liang MH. The epidemiology of systemic lupus erythematosus in populations of African ancestry: A critical review of the "prevalence gradient hypothesis". Arthritis Rheum 1998;41:2091-9.
18. Clark IA, al-Yaman FM, Cowden WB, Rockett KA. Does malarial tolerance, through nitric oxide, explain the low incidence of autoimmune disease in tropical Africa? Lancet 1996;348:1492-4. '
19. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
20. Jessop S, Meyers OL. Systemic lupus erythematosus in Cape Town. S Afr Med J 1973;47:222-5.
21. Dessein PH, Gledhill RF, Rossouw DS. Systemic lupus erythematesus in black South Africans. S Afr Med J 1988;74:387-9.
22. Walsh SJ, Algert C, Gregorio DI, Reisine ST, Rothfield NF. Divergent racial trends in mortality from systemic lupus erythematosus. J Rheumatol 1995;22:1663-8.
23. Alarcon GS, Friedman AW, Straiston KV et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in Minority. populations: NAture vs. Nurture. Lupus 1999;8:197-209.
24. Alba P, Bento L, Cuadrado MJ et al. Anti-DNA, anti-Sm antibodies, and the lupus anticoagulant: Significant factors associated with lupus nephritis. Ann Rheum Dis 2003;62:556-60.
25. Bastian HM, Roseman JM, McGwin G Jr et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 2002;11:152-80.
26. Cervera R, Khamashta MA, Font J et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1,000 patients. Medicine 2003;82:299-308.
27. Walsh SJ, DeChello LM. Geographical variation in mortality from systemic lupus erythematosus in the United States. Lupus 2001;10:637-46.
28. Ansell SM, Bedhesi S, Ruff B et al. Study of critically ill patents with systemic lupus erythematosus. Crit Care Med 1996;24:981-4.
29. Whitelaw DA, Gopal R, Freeman V. Survival of patients with SLE admitted to an intensive care unit-a retrospective study. Clin Rheumatol 2005;24;223-7.
30. Mody GM, Parag KB, Nathoo BC, Pudifin DJ, Duursma J, Seadat YK. High mortality with systemic lupus erythematosus in hospitalized African blacks. Br J Rheumatol 1994;33:1151-3.
31. Sayarlioglu M, Inanc M, Kernel S et al. Tuberculosis in Turkish patients with systemic lupus erythematosus: Increased frequency of extrapulmonary localization. Lupus 2004;13:274-8.
32. Hodkinson B, Tildy M. Tuberculosis in systemic lupus erythematosus patients in South Africa. Ann Rheum Dis 2006;65(Suppi II):198.
33. Kang I, Park SH. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol 2003;15:528-34.
34. Seedat YK. Ethnicity, hypertension, coronary heart disease and renal diseases in South Africa. Ethn Health 1996;1:349-57.